An FDA panel is about to convene next week to approve CV19 shots for CHILDREN 6 MONTHS - 4 YEARS OLD.

Deadline for comments is June 7th, but they will take late submissions until June 13th.

Agenda: The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On June 14, 2022, under Topic 1, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. On June 15, 2022, under Topic II, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age and to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and CHILDREN 6 MONTHS through 4 years of age.

World Council for Health Urgent Message:

https://brandnewtube.com/watch/urgent-tell-the-fda-no-covid-19-shots-for-babies-and-children_wfCCJCPhyiHuquF.html

FDA Notice; establishment of a public docket; request for comments:

https://www.regulations.gov/document/FDA-2022-N-0904-0001